Financial Snapshot

Revenue
$423.7M
TTM
Gross Margin
81.34%
TTM
Net Earnings
$153.7M
TTM
Current Assets
$808.4M
Q3 2024
Current Liabilities
$75.70M
Q3 2024
Current Ratio
1067.92%
Q3 2024
Total Assets
$824.0M
Q3 2024
Total Liabilities
$87.14M
Q3 2024
Book Value
$736.9M
Q3 2024
Cash
$164.8M
Q3 2024
P/E
10.68
Nov 29, 2024 EST
Free Cash Flow
$161.0M
TTM

Revenues

Revenues

Loading...

Revenue YoY Change

Loading...

Revenues

Concept 2023 2022 2021 2020 2019 2018 2017 2016
Revenue $492.0M $454.3M $357.6M $206.1M $156.4M $100.2M $53.50M $23.10M
YoY Change 8.32% 27.05% 73.49% 31.78% 56.09% 87.29% 131.6%

Expenses

Cost Of Revenues

Loading...

Gross Profit

Loading...

Gross Profit Margin

Loading...

Gross Profit

Concept 2023 2022 2021 2020 2019 2018 2017 2016
Revenue $492.0M $454.3M $357.6M $206.1M $156.4M $100.2M $53.50M $23.10M
Cost Of Revenue $80.71M $73.49M $53.59M $30.80M $20.20M $15.10M $9.100M $5.700M
Gross Profit $411.3M $380.8M $304.0M $175.3M $136.1M $85.10M $44.40M $17.40M
Gross Profit Margin 83.6% 83.82% 85.01% 85.06% 87.02% 84.93% 82.99% 75.32%

Selling, General & Admin Expense

Loading...

Research & Development

Loading...

Depreciation, Depletion & Amortization

Loading...

SGA Expense to Gross Profit Ratio

Loading...

R&D To Gross Profit Ratio

Loading...

DDA To Gross Profit Ratio

Loading...

Operating Expenses Total

Loading...

Operating Profits/Loss

Loading...

Operational Expenses

Concept 2023 2022 2021 2020 2019 2018 2017 2016
Selling, General & Admin $202.3M $170.5M $127.8M $93.00M $70.80M $49.40M $32.90M $14.30M
YoY Change 18.63% 33.45% 37.38% 31.36% 43.32% 50.15% 130.07%
% of Gross Profit 49.17% 44.78% 42.03% 53.05% 52.02% 58.05% 74.1% 82.18%
Research & Development $13.41M $12.43M $9.532M $9.500M $5.700M $4.200M $2.600M $2.500M
YoY Change 7.93% 30.35% 0.34% 66.67% 35.71% 61.54% 4.0%
% of Gross Profit 3.26% 3.26% 3.14% 5.42% 4.19% 4.94% 5.86% 14.37%
Depreciation & Amortization $623.0K $680.0K $517.0K $420.0K $300.0K $180.0K $200.0K $150.0K
YoY Change -8.38% 31.53% 23.1% 40.0% 66.67% -10.0% 33.33%
% of Gross Profit 0.15% 0.18% 0.17% 0.24% 0.22% 0.21% 0.45% 0.86%
Operating Expenses $215.7M $182.9M $136.5M $102.5M $76.50M $53.60M $35.40M $16.70M
YoY Change 17.9% 34.02% 33.17% 33.99% 42.72% 51.41% 111.98%
Operating Profit $195.7M $197.9M $167.5M $72.80M $59.60M $31.50M $9.000M $700.0K
YoY Change -1.11% 18.14% 130.05% 22.15% 89.21% 250.0% 1185.71%

Interest Expenses

Loading...

Interest Expenses To Operating Income %

Loading...

Other Expense/Income

Loading...

Interest & Other Expense/Income

Concept 2023 2022 2021 2020 2019 2018 2017 2016
Interest Expense $21.61M $3.612M $525.0K $3.300M $2.400M $100.0K $800.0K $0.00
YoY Change 498.2% 588.0% -84.09% 37.5% 2300.0% -87.5%
% of Operating Profit 11.04% 1.83% 0.31% 4.53% 4.03% 0.32% 8.89% 0.0%
Other Income/Expense, Net
YoY Change

Income/Loss

Pretax Income

Loading...

Income Tax

Loading...

Net Profits/Loss

Loading...

Pretax Income YoY Change

Loading...

Income Tax Rate

Loading...

Net Profits/Loss YoY Change

Loading...

Basic EPS

Loading...

Net Income To Revenue Ratio

Loading...

Pretax & Net Income

Concept 2023 2022 2021 2020 2019 2018 2017 2016
Pretax Income $217.3M $201.5M $168.0M $76.10M $62.00M $23.60M $9.800M $700.0K
YoY Change 7.84% 19.92% 120.76% 22.74% 162.71% 140.82% 1300.0%
Income Tax $19.35M $39.95M $2.928M $1.100M $900.0K $1.300M $1.400M $300.0K
% Of Pretax Income 8.91% 19.83% 1.74% 1.45% 1.45% 5.51% 14.29% 42.86%
Net Earnings $197.9M $161.5M $165.0M $75.00M $61.10M $22.40M $8.800M $300.0K
YoY Change 22.54% -2.09% 119.96% 22.75% 172.77% 154.55% 2833.33%
Net Earnings / Revenue 40.22% 35.56% 46.14% 36.39% 39.07% 22.36% 16.45% 1.3%
Basic Earnings Per Share $2.37 $1.96 $2.03 $1.04
Diluted Earnings Per Share $2.30 $1.89 $1.918M $1.781M $1.604M $702.2K $275.9K $9.404K

Assets & Liabilities

Cash & Short-Term Investments

Loading...

Cash & Equivalents

Loading...

Cash To Operating Expenses Ratio

Loading...

Inventory

Loading...

Receivables

Loading...

Total Short-Term Assets

Loading...

Property, Plant And Equipment

Loading...

Long-Term Investments

Loading...

Total Long-Term Assets

Loading...

Total Assets

Loading...

Net Income To Total Assets Percentage

Loading...

Accounts Payable

Loading...

Short-Term Debt

Loading...

Long Term Debt Due

Loading...

Total Short-Term Liabilities

Loading...

Long-Term Debt

Loading...

Other Long-Term Liabilities

Loading...

Total Long-Term Liabilities

Loading...

Total Liabilities

Loading...

Short-Term To Long-Term Debt Ratio

Loading...

Short-Term Assets To Debt Ratio

Loading...

Long-Term Debt To Net Income Ratio

Loading...

Assets & Liabilities

Concept 2023 2022 2021 2020 2019 2018 2017 2016
Cash & Short-Term Investments $741.6M $547.4M $415.9M $260.5M $193.4M $61.30M $25.00M $8.300M
YoY Change 35.48% 31.61% 59.66% 34.69% 215.5% 145.2% 201.2%
Cash & Equivalents $144.4M $97.54M $68.14M $68.90M $44.70M $24.70M $17.60M $6.700M
Short-Term Investments $373.6M $374.6M $294.5M $142.0M $120.1M $26.50M $7.400M $1.600M
Other Short-Term Assets
YoY Change
Inventory $45.10M $39.90M $21.03M $15.00M $9.400M $7.000M $5.000M $2.800M
Prepaid Expenses
Receivables $40.72M $24.57M $17.93M $8.200M $5.400M $5.900M $5.200M $2.900M
Other Receivables $17.91M $17.52M $15.24M $5.900M $5.000M $3.600M $1.900M $400.0K
Total Short-Term Assets $845.3M $629.4M $470.1M $289.6M $213.2M $77.80M $37.10M $14.30M
YoY Change 34.31% 33.88% 62.33% 35.83% 174.04% 109.7% 159.44%
Property, Plant & Equipment $12.08M $7.371M $5.725M $2.100M $2.300M $500.0K $300.0K $400.0K
YoY Change 63.89% 28.75% 172.62% -8.7% 360.0% 66.67% -25.0%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $700.0K $600.0K $600.0K $600.0K $600.0K
YoY Change 16.67% 0.0% 0.0% 0.0%
Other Assets $1.506M $3.094M $1.334M $100.0K $1.900M $2.200M $800.0K $200.0K
YoY Change -51.33% 131.93% 1234.0% -94.74% -13.64% 175.0% 300.0%
Total Long-Term Assets $17.96M $15.04M $8.427M $6.200M $5.200M $3.300M $2.300M $2.200M
YoY Change 19.4% 78.45% 35.92% 19.23% 57.58% 43.48% 4.55%
Total Assets $863.3M $644.4M $478.5M $295.8M $218.4M $81.10M $39.40M $16.50M
YoY Change
Accounts Payable $13.97M $16.24M $8.779M $6.400M $3.700M $4.500M $3.100M $1.600M
YoY Change -14.01% 85.01% 37.17% 72.97% -17.78% 45.16% 93.75%
Accrued Expenses $23.44M $20.89M $19.02M $14.70M $8.800M $15.50M $6.000M $1.700M
YoY Change 12.22% 9.87% 29.36% 67.05% -43.23% 158.33% 252.94%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $64.14M $82.02M $51.85M $35.00M $32.50M $29.40M $13.50M $7.400M
YoY Change -21.8% 58.19% 48.14% 7.69% 10.54% 117.78% 82.43%
Long-Term Debt $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $11.78M $7.771M $10.89M $5.300M $6.100M $4.800M $3.400M $0.00
YoY Change 51.56% -28.63% 105.45% -13.11% 27.08% 41.18%
Total Long-Term Liabilities $11.78M $7.771M $10.89M $5.300M $6.100M $4.800M $3.400M $0.00
YoY Change 51.56% -28.63% 105.45% -13.11% 27.08% 41.18%
Total Liabilities $75.91M $89.79M $62.74M $41.80M $42.30M $37.80M $20.00M $7.600M
YoY Change -15.45% 43.12% 50.09% -1.18% 11.9% 89.0% 163.16%

Ownership

Basic Shares Outstanding

Loading...

Diluted Shares Outstanding

Loading...

Preferred Stock

Loading...

Treasury Stock Shares

Loading...

Stock Issuance & Repurchase

Loading...

Ownership Data

Concept 2023 2022 2021 2020 2019 2018 2017 2016
Basic Shares Outstanding 83.53M shares 82.48M shares 81.44M shares 72.11M shares
Diluted Shares Outstanding 85.95M shares 85.40M shares 86.02M shares 84.18M shares
Preferred Stock
Treasury Stock Shares

Return On Shareholders' Equity

Loading...

Book Value

Loading...

Free Cash Flow

Loading...

Free Cash Flow YoY

Loading...

Free Cash Flow Margin

Loading...

Dividends

Dividends

Loading...

Stock Price

Loading...
Market Cap: $1.6416 Billion

About InMode Ltd.

InMode Ltd. designs, develops, manufactures and markets minimally-invasive aesthetic medical products. Company's products and solutions are primarily designed to address three energy-based treatment categories comprised of: face and body contouring; medical aesthetics; and women’s health. The firm have developed and commercialized products utilizing medically-accepted RF energy technology, which can penetrate deep into the subdermal fat, allowing adipose tissue remodeling. It's RF energy-based proprietary technologies - Radio Frequency Assisted Lipolysis (RFAL), Deep Subdermal Fractional RF, Simultaneous Fat Destruction and Skin Tightening and Deep Heating Collagen Remodeling for skin and human natural openings- represent a paradigm shift in the minimally-invasive aesthetic solutions market. These technologies are used by physicians to remodel subdermal adipose, or fatty tissue in a variety of procedures.

Industry: Electromedical & Electrotherapeutic Apparatus Peers: Alpha Tau Medical Ltd. Nano-X Imaging Ltd.